2023-504696-24-00Not yet recruitingPhase 1/2
The ALPINE trial: a phase 1-2 study of intra-arterial [177Lu]Lu-PSMA-I&T for progressive or recurrent intracranial adult type diffuse glioma
Source: EU CTIS (euclinicaltrials.eu) · Last updated 13 May 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- First submitted
- 20 Apr 2023
- Start date
- 1 Dec 2025
- Lead sponsor
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
- Diseases
- Glioblastoma
- EU CT number
- 2023-504696-24-00
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 28
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a brain tumour called diffuse glioma that has grown or come back.
- Age
- 18 to 64 years
- Sex
- All sexes can join.
- Disease stage
- Diffuse glioma (diffuse astrocytoma, oligodendroglioma or glioblastoma) inside the skull that is progressing or has recurred.
Read by machine on 9 Nov 2026.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) | Rotterdam | Netherlands | Not yet recruiting |
| St. Olavs hospital HF | Trondheim | Norway | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.